Н. А. Царева

409 total citations
25 papers, 125 citations indexed

About

Н. А. Царева is a scholar working on Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Н. А. Царева has authored 25 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 6 papers in Critical Care and Intensive Care Medicine and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Н. А. Царева's work include Pulmonary Hypertension Research and Treatments (13 papers), Respiratory Support and Mechanisms (10 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Н. А. Царева is often cited by papers focused on Pulmonary Hypertension Research and Treatments (13 papers), Respiratory Support and Mechanisms (10 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Н. А. Царева collaborates with scholars based in Russia and Germany. Н. А. Царева's co-authors include С. Н. Авдеев, Н. В. Трушенко, Andrey I. Yaroshetskiy, З. М. Мержоева, S. Yu. Chikina, Djuro Kosanovic, Ralph T. Schermuly, И Е Чазова, А. В. Волков and Irina A. Mandel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Critical Care and Annals of Emergency Medicine.

In The Last Decade

Н. А. Царева

18 papers receiving 117 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Н. А. Царева Russia 6 98 40 30 25 17 25 125
Johanna Oziel France 4 53 0.5× 41 1.0× 27 0.9× 14 0.6× 11 0.6× 4 107
Anna Geke Algera Netherlands 6 107 1.1× 67 1.7× 36 1.2× 18 0.7× 4 0.2× 10 121
Parag Desai United States 5 75 0.8× 25 0.6× 18 0.6× 11 0.4× 10 0.6× 14 135
Mohamed Helmy Egypt 6 43 0.4× 12 0.3× 15 0.5× 21 0.8× 8 0.5× 14 119
Enrico Allegorico Italy 4 37 0.4× 48 1.2× 14 0.5× 7 0.3× 10 0.6× 9 80
Jean-Loup Augy France 4 66 0.7× 29 0.7× 36 1.2× 15 0.6× 5 0.3× 8 88
Laura Claverías Spain 6 33 0.3× 24 0.6× 10 0.3× 13 0.5× 12 0.7× 14 84
Safaa Nemlaghi France 4 26 0.3× 30 0.8× 18 0.6× 9 0.4× 8 0.5× 6 94
Sunny G. L. H. Nijbroek Netherlands 7 92 0.9× 37 0.9× 18 0.6× 8 0.3× 46 2.7× 11 126
Mayson Laércio de Araújo Sousa Brazil 6 90 0.9× 50 1.3× 37 1.2× 6 0.2× 6 0.4× 21 125

Countries citing papers authored by Н. А. Царева

Since Specialization
Citations

This map shows the geographic impact of Н. А. Царева's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Н. А. Царева with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Н. А. Царева more than expected).

Fields of papers citing papers by Н. А. Царева

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Н. А. Царева. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Н. А. Царева. The network helps show where Н. А. Царева may publish in the future.

Co-authorship network of co-authors of Н. А. Царева

This figure shows the co-authorship network connecting the top 25 collaborators of Н. А. Царева. A scholar is included among the top collaborators of Н. А. Царева based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Н. А. Царева. Н. А. Царева is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Царева, Н. А., Andrey I. Yaroshetskiy, Olga Suvorova, et al.. (2024). Efficacy and safety of high doses of inhaled nitric oxide in patients with community-acquired pneumonia: a pilot study. PULMONOLOGIYA. 34(3). 417–426.
3.
Царева, Н. А., et al.. (2023). Long-term oxygen therapy for chronic obstructive pulmonary disease: results from an observational cohort study. Meditsinskiy sovet = Medical Council. 86–94.
4.
Мержоева, З. М., Andrey I. Yaroshetskiy, Irina A. Mandel, et al.. (2023). Cyclosporine A therapy in patients with COVID-19 and failure of immunosuppression therapy: a retrospective cohort propensity-score matched analysis. SHILAP Revista de lepidopterología. 125–138. 1 indexed citations
5.
Трушенко, Н. В., Olga Suvorova, S. Yu. Chikina, et al.. (2023). Predictors of Pulmonary Hypertension and Right Ventricular Dysfunction in Patients with Hypersensitivity Pneumonitis. Life. 13(6). 1348–1348. 3 indexed citations
6.
Царева, Н. А.. (2023). Mechanisms of pulmonary hypertension development in COVID-19. PULMONOLOGIYA. 33(4). 525–532.
7.
Yaroshetskiy, Andrey I., С. Н. Авдеев, З. М. Мержоева, et al.. (2022). Potential for the lung recruitment and the risk of lung overdistension during 21 days of mechanical ventilation in patients with  COVID-19 after noninvasive ventilation failure: the COVID-VENT observational trial. BMC Anesthesiology. 22(1). 59–59. 6 indexed citations
9.
Авдеев, С. Н., Н. В. Трушенко, S. Yu. Chikina, et al.. (2021). Beneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome. Respiratory Medicine. 185. 106489–106489. 17 indexed citations
11.
Авдеев, С. Н., Н. А. Царева, З. М. Мержоева, Н. В. Трушенко, & Andrey I. Yaroshetskiy. (2020). Practical guidance for oxygen treatment and respiratory support of patients with COVID-19 infection before admission to intensive care unit. PULMONOLOGIYA. 30(2). 151–163. 14 indexed citations
12.
Авдеев, С. Н., et al.. (2020). Exacerbation of idiopathic pulmonary fibrosis. SHILAP Revista de lepidopterología. 92(3). 73–77. 2 indexed citations
13.
Авдеев, С. Н., Andrey I. Yaroshetskiy, Н. А. Царева, et al.. (2020). Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19. The American Journal of Emergency Medicine. 39. 154–157. 31 indexed citations
15.
Авдеев, С. Н., et al.. (2018). INFLUENCE OF PULMONARY HYPERTENSION ON CLINICAL COURSE AND PROGNOSIS OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Russian Journal of Cardiology. 173–179. 1 indexed citations
16.
Авдеев, С. Н., et al.. (2018). Combination therapy is a new standard for treatment of pulmonary arterial hypertension. Terapevticheskii arkhiv. 90(3). 72–80. 2 indexed citations
17.
Царева, Н. А., et al.. (2017). A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out?. Terapevticheskii arkhiv. 89(9). 100–103. 2 indexed citations
18.
Царева, Н. А.. (2017). Updated classification and diagnosis of pulmonary hypertension. Consilium Medicum. 19(3). 66–71. 1 indexed citations
19.
Царева, Н. А., et al.. (2016). Sequential Combination Therapy in a Patient With Idiopathic Pulmonary Arterial Hypertension. Kardiologiia. 3_2016(3). 97–100. 2 indexed citations
20.
Чазова, И Е, et al.. (2014). [Clinical guidelines for the diagnosis and treatment of pulmonary hypertension].. PubMed. 86(9). 4–23. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026